Showing results (1081-1090 of 4,634) with videos related to

Sort By:
Pageof 464
Anti-Cancer Drugs|January 17, 2026
Isovanillin regulates gastric cancer cells apoptosis and metastasis by targeting ROS-mediated MAPK and PI3K signaling pathwaysJing-Jing Wen, Xiao-Yu Jin, Ying-Hua Luo, et al.
Anti-Cancer Drugs|January 28, 2026
Human Epidermal Growth Factor Receptor-2 positive metastatic salivary duct carcinoma with remarkable response to targeted therapy: a case report and therapeutic implicationsClara Rodrigo Juan, Carla Climent Vicente, Francisco Xavier Avilés Jurado, et al.
Anti-Cancer Drugs|January 28, 2026
Dual checkpoint inhibition achieves successful treatment of diffuse bilateral lung metastasis in giant advanced liver cancer: a case reportTing-Ting Xie, Wang Chen, Zi-Han Zeng, et al.
Anti-Cancer Drugs|January 8, 2025
A dual thermo/pH-sensitive hydrogel as 5-Fluorouracil carrier for breast cancer treatmentKairan Luo, Wenbin Hu
Anti-Cancer Drugs|January 14, 2025
Clinical efficacy of pyrotinib combined with chemotherapy for neoadjuvant treatment in HER2-positive breast cancer: a single-center studyBenkai Wei, Huanhuan Yan, Fan Li, et al.
Anti-Cancer Drugs|January 9, 2025
Stereotactic body radiotherapy and poly (ADP-ribose) polymerase inhibitors in ovarian cancer: a knowledge and attitudes survey in collaboration with the Italian Association of Radiation Oncology (AIRO) and Multicenter Italian Trials in Ovarian Cancer (MITO) groupsGabriella Macchia, Donato Pezzulla, Donatella Russo, et al.
Anti-Cancer Drugs|January 2, 2024
Suppression of DNMT1 combined with ATM or ATR inhibitor as a therapeutic combination of acute myeloid leukemiaLei Liu, Xiaoyan Hu, Jing Feng, et al.
Anti-Cancer Drugs|December 1, 2023
HER2-positive advanced biliary tract cancer responds to second-line pyrotinib therapy: a case reportLinger Liu, Yao Chen, Xiaolian Zhu, et al.
Anti-Cancer Drugs|November 29, 2023
Design of potential anti-cancer agents as COX-2 inhibitors, using 3D-QSAR modeling, molecular docking, oral bioavailability proprieties, and molecular dynamics simulationMohammed Er-Rajy, Mohamed El Fadili, Abdelmoujoud Faris, et al.
Anti-Cancer Drugs|November 29, 2023
Impact of antihistamine use on the survival outcomes of immune checkpoint inhibitors in advanced cancer patientsEda Eylemer Mocan, Emre Yekedüz, Göktürk Karataş, et al.
Pageof 464